SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.810.0%Nov 24 3:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eric Klein who wrote (5008)12/5/1997 12:45:00 PM
From: aknahow  Read Replies (2) of 17367
 
Eric, I also subscribe to CTSL and was pleased when he included Xoma as one of his picks.

In general terms if BPI proves itself as a means of combating resistance to antibiotics I would hink that it would be effective in many different pplications. However, what I find strange is that if the potential is so obvious, why has the market overlooked XOMA?

It would seem the market does not believe the potential is as great as I might think. Realize we have gone back and forth on this issue for a long time. I recognize the market is not efficient and that the pricing of stocks like CORR & IDPH changed overnight on events that were obvious to posters on their threads but ignored by the market until further clarified.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext